Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023

Cost and committee reports

Official records Congress.gov attaches to H.R. 3093.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. HOYLE of Oregon, as printed in the Congressional Record (Vol. 169, No. 77, May 5, 2023, Page H2137):
  This bill is enacted pursuant to the power granted to Congress under Article I of the United States Constitution and its subsequent amendments, and further clarified and interpreted by the Supreme Court of the United States. The single subject of this legislation is: To ensure affordable pricing for taxpayer-funded prescription drugs.
  Source: Congress.gov, Congressional Record May 5, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  336 characters

  Congress.gov bill record

  H.R. 3093, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/3093

  Record last updated by Congress.gov

  July 24, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  6ff47735824ed34d91cc63ea82b632ed4f352d066574a556a787402acc1ba5af

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of July 24, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 3093, last updated July 24, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.